WO2004063150A3 - Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process - Google Patents
Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process Download PDFInfo
- Publication number
- WO2004063150A3 WO2004063150A3 PCT/US2003/041731 US0341731W WO2004063150A3 WO 2004063150 A3 WO2004063150 A3 WO 2004063150A3 US 0341731 W US0341731 W US 0341731W WO 2004063150 A3 WO2004063150 A3 WO 2004063150A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- alkyl
- hydrogen
- phenyl
- same
- alkynyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D213/72—Nitrogen atoms
- C07D213/75—Amino or imino radicals, acylated by carboxylic or carbonic acids, or by sulfur or nitrogen analogues thereof, e.g. carbamates
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/08—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms
- C07D211/18—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D211/26—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hydrocarbon or substituted hydrocarbon radicals directly attached to ring carbon atoms with substituted hydrocarbon radicals attached to ring carbon atoms with hydrocarbon radicals, substituted by nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/06—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D211/36—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D211/56—Nitrogen atoms
- C07D211/58—Nitrogen atoms attached in position 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D295/00—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
- C07D295/16—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms
- C07D295/20—Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms acylated on ring nitrogen atoms by radicals derived from carbonic acid, or sulfur or nitrogen analogues thereof
- C07D295/215—Radicals derived from nitrogen analogues of carbonic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Abstract
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
AU2003300147A AU2003300147A1 (en) | 2003-01-06 | 2003-12-31 | Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US43788503P | 2003-01-06 | 2003-01-06 | |
US60/437,885 | 2003-01-06 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2004063150A2 WO2004063150A2 (en) | 2004-07-29 |
WO2004063150A3 true WO2004063150A3 (en) | 2005-06-02 |
Family
ID=32713245
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2003/041731 WO2004063150A2 (en) | 2003-01-06 | 2003-12-31 | Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU2003300147A1 (en) |
WO (1) | WO2004063150A2 (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101819472B1 (en) * | 2017-02-14 | 2018-01-17 | 전남대학교산학협력단 | Novel 1,4-substituted piperazine or piperidine compounds and pharmaceutical composition comprising the same |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4476129A (en) * | 1982-06-29 | 1984-10-09 | Gist-Brocades N.V. | 4-[2-[Bis(halophenyl)methoxy]-ethyl]-α-(substituted phenyl)-1-piperazinealkanol derivatives, processes for their preparation and pharmaceutical preparations containing them |
US5652240A (en) * | 1992-07-31 | 1997-07-29 | Pharmacia Aktiebolag | Pyridyl-and pyrimidylpiperazine derivatives |
US6387389B1 (en) * | 1996-10-31 | 2002-05-14 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use |
-
2003
- 2003-12-31 WO PCT/US2003/041731 patent/WO2004063150A2/en not_active Application Discontinuation
- 2003-12-31 AU AU2003300147A patent/AU2003300147A1/en not_active Abandoned
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4476129A (en) * | 1982-06-29 | 1984-10-09 | Gist-Brocades N.V. | 4-[2-[Bis(halophenyl)methoxy]-ethyl]-α-(substituted phenyl)-1-piperazinealkanol derivatives, processes for their preparation and pharmaceutical preparations containing them |
US5652240A (en) * | 1992-07-31 | 1997-07-29 | Pharmacia Aktiebolag | Pyridyl-and pyrimidylpiperazine derivatives |
US6387389B1 (en) * | 1996-10-31 | 2002-05-14 | The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services | Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy]ethyl]-piperazines and -homopiperazines and their use |
Also Published As
Publication number | Publication date |
---|---|
AU2003300147A8 (en) | 2004-08-10 |
WO2004063150A2 (en) | 2004-07-29 |
AU2003300147A1 (en) | 2004-08-10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JO2613B1 (en) | Organic Compounds | |
MX2009004900A (en) | Thiazole and oxazole-substituted arylamides. | |
MX2008016423A (en) | Tetrazole-substituted arylamides. | |
BR122012009489B8 (en) | process for producing 2-ethoxy-1-{[2-(5-oxo-4,5-dihydro-1,2,4-oxadiazol-3-yl)biphenyl-4-yl]methyl}-1h-benzimidazol- (5-methyl-2-oxo-1,3-dioxol-4-yl)methyl 7-carboxylate or a salt thereof, pharmaceutical composition, and use | |
NO20085169L (en) | Crystalline solvates and complexes of (1S) -1,5-anhydro-L-C- (3 - ((phenyl) methyl) phenyl) -D-glucitol derivatives with amino acids as SGLT2 inhibitors for the treatment of diabetes | |
DE602007004851D1 (en) | A2A ADENOSINE RECEPTOR ANTAGONISTS | |
IL183876A0 (en) | Aminocarboxylic acid derivative and medicinal use thereof | |
ATE515505T1 (en) | HETEROCYCLIC FXR BINDING COMPOUNDS | |
NO20055688L (en) | Organic compounds | |
NO20060324L (en) | [1,8] Naphthyridin-2-ones and related compounds for the treatment of schizophrenia | |
WO2006023881A3 (en) | T type calcium channel blockers and the treatment of diseases | |
EP1627635A3 (en) | Benzothiazolium compounds for use in methods of inhibiting NO production and TNF alpha and treating coronaviral infection | |
WO2005030120A3 (en) | Antiangiogenic agents | |
WO2009018065A3 (en) | Novel glucokinase activators and methods of using same | |
IL183373A0 (en) | 3-[2-(3-acylamino-2-oxo-2h-pyridin-1-yl)-acetylamino]-4-oxo-pentanoic acid derivatives, pharmaceutical compositions containing the same and methods for the preparation thereof | |
EP1817311A4 (en) | 2,3,4,6-substituted pyridyl derivative compounds useful as beta-secretase inhibitors for the treatment of alzheimer's disease | |
MY147404A (en) | Process for preparation of n-benzoyl-staurosporine | |
WO2007025897A3 (en) | Benzooxazole, oxazolopyridine, benzothiazole and thiazolopyridine derivatives | |
WO2006003013A3 (en) | NOVEL 2-SUBSTITUTED ESTRA-1,3,5(10)-TRIEN-17-ONES USED IN THE FORM OF INHIBITORS OF 17β-HYDROXYSTEROIDDEHYDROGENASE OF TYPE 1 | |
HUP0303034A2 (en) | Novel 7-azaindole-derivatives, use thereof as phosphodiesterase 4 inhibitors and method for producing the same | |
NO20062202L (en) | Amidomethyl-substituted 2- (4-sulfonylamino) -3-hydroxy-3,4-dihydro-2H-chromene-6-yl derivatives, processes and intermediates for their preparation, and drugs containing these compounds | |
WO2004067482A3 (en) | Substituted anilide ligands for the thyroid receptor | |
WO2004066929A3 (en) | Cycloalkyl containing anilide ligands for the thyroid receptor | |
NO20074346L (en) | New heterocyclic oxime compounds, processes for their preparation and pharmaceutical compositions containing them | |
GB0428416D0 (en) | Organic compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AK | Designated states |
Kind code of ref document: A2 Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CN CO CR CU CZ DE DK DM DZ EC EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NI NO NZ OM PG PH PL PT RO RU SC SD SE SG SK SL SY TJ TM TN TR TT TZ UA UG UZ VC VN YU ZA ZM ZW |
|
AL | Designated countries for regional patents |
Kind code of ref document: A2 Designated state(s): BW GH GM KE LS MW MZ SD SL SZ TZ UG ZM ZW AM AZ BY KG KZ MD RU TJ TM AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IT LU MC NL PT RO SE SI SK TR BF BJ CF CG CI CM GA GN GQ GW ML MR NE SN TD TG |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application | ||
122 | Ep: pct application non-entry in european phase | ||
NENP | Non-entry into the national phase |
Ref country code: JP |
|
WWW | Wipo information: withdrawn in national office |
Country of ref document: JP |